Carlsmed

Carlsmed

Health Care Equipment & Supplies
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient’s unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures.

$366.1M

Market Cap • 10/16/2026

2018

(8 years)

Founded

2025

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

4,3

P/S

5,8

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

3,1

EPS

—

Market Cap

Market Cap

366,1M

EV

298,7M

EV/Revenue

4,7

EV/EBITDA

-7,8

EV/EBIT

-7,7

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-25,7%

Total Yield

-25,7%

Payout

0%

Retained Earnings

-120M

Profitability

Gross Margin

76,6%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

33,1%

Capex/Revenue

0,7%

Capex/D&A

105,6%

Capex/OCF

-1,3%

SBC/OCF

—

% PPE

7,1%

% Goodwill

0%

ROE

—

ROIC

—

Leverage

N.D./EBITDA

1,8

Debt/Equity

0%

Current Ratio

8,8

Quick Ratio

8,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium